G. Oliviéro - Concepedia

Author

G. Oliviéro

Also Known As

G Oliviero, G. Oliviero, G. Oliviéro, G., Oliviero, Gerard Oliviero, Giuseppe Oliviero, Gérard Oliviero, Gérard Oliviéro

Publications

822

Citations

H-Index

Concepts

All Affiliations

Assistance Publique – Hôpitaux de Paris Inserm Centre Hospitalier Régional Universitaire de Brest Sorbonne Université Hôpital Intercommunal de Créteil

About

G. Oliviéro is an author at Assistance Publique – Hôpitaux de Paris specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	709
2	Pathology	2	2	42
3	Epidemiology	1	1	556
4	Microbiology	1	1	556
5	Pharmacology	1	1	12

G. Oliviéro

Publications

807

Citations

H-Index

Page 1

	Year	Citations
Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study Caroline Charlier, Élodie Perrodeau, Alexandre Leclercq, The Lancet Infectious Diseases Prognostic FactorsFoodborne IllnessClinical FeaturesMicrobiologyInfection Control	2017	556
Prospective screening for ALK: Clinical features and outcome according to ALK status Vincent Fallet, Jacques Cadranel, H. Doubre, European Journal of Cancer Clinical EpidemiologyDiagnosisClinical FeaturesMedicineProspective Screening	2014	55
Anti-tumour effect of low molecular weight heparin in localised lung cancer: a phase III clinical trial Guy Meyer, Benjamin Besse, H. Doubre, European Respiratory Journal	2018	55
Prediagnosis weight loss, a stronger factor than BMI, to predict survival in patients with lung cancer Hugues Morel, Bruno Raynard, M. D’arlhac, Lung Cancer Stronger FactorMedicineEpidemiology Of CancerPrognosisOncology	2018	42
Two biomarker-directed randomized trials in European and Chinese patients with nonsmall-cell lung cancer: the BRCA1-RAP80 Expression Customization (BREC) studies Teresa Morán, Jia Wei, Manuel Cobo, Annals of Oncology OncologyMedicinePathologyBrca1-rap80 Expression CustomizationBiomarker-directed Randomized Trials	2014	30
Management of malignant pleural mesothelioma: a French multicenter retrospective study (GFPC 0802 study) C. Raynaud, Laurent Greillier, Julien Mazières, BMC Cancer	2015	17
Circulating free tumor-derived DNA to detect EGFR mutations in patients with advanced NSCLC: French subset analysis of the ASSESS study Marc G. Denis, M.-P. Lafourcade, G. Le Garff, Journal of Thoracic Disease	2019	15
Assessment of palliative care for advanced non-small-cell lung cancer in France: A prospective observational multicenter study (GFPC 0804 study) A. Vergnenègre, S. Hominal, Achille Tchalla, Lung Cancer Palliative CareEnd-of-life CareMedicineCancer ManagementGfpc 0804	2013	14
Erlotinib<i>versus</i>carboplatin and paclitaxel in advanced lepidic adenocarcinoma: IFCT-0504 Jacques Cadranel, Radj Gervais, P. Merle, European Respiratory Journal Tumor BiologyMedicinePharmacologyDisease ControlPathology	2015	12
[Lung disease induced by isotretinoin]. G. Oliviéro, P Constans, Isabelle Caby, PubMed	1995	11

Page 1